India 120 capsules Gleevec purchasing agent 18210766570 new version Gleevec price

Lu Yong, a patient with chronic myelogenous leukemia at the consultation hotline, discovered that India’s imitation of the Swiss Gleevec anti-cancer drug not only saved domestic patients with chronic myelogenous leukemia more than 10,000 yuan per month in drug expenses, but also meant that their hope of survival greatly increased, so he helped thousands of them. Patients buy this medicine. However, this kind of generic drug has not been approved by the domestic drug regulatory authorities and is considered a fake drug. Recently, Lu Yong was prosecuted on suspicion of selling counterfeit drugs. "Beijing Times" on March 29
Life or death is not just a Hamlet-like dilemma, but a real dilemma that patients whose life-saving medicines turn out to be counterfeit have to face. For patients who cannot afford to take multiple genuine medicines every month, they thought that cheap generic medicines were a life-saving straw. However, in order to survive spontaneously, they fell into the quagmire of fake medicines. Patients who bought medicines for their fellow patients became salesmen. Suspect of counterfeit drugs. To abide by the law is to wait for death, but to live in violation of the law. What is more disturbing and helpless than the disease is probably the mutual exclusion and deadlock between life and the law.
It is undeniable that since drugs are related to health and life, the review and identification of drugs are certainly not optional. Even in accordance with international practice, the United States and the European Food and Drug Administration all adopt strict supervision of drugs to encourage the development of new drugs and ensure drug safety. In this sense, whether it is a domestically produced drug or an imported drug, if it wants to be sold in the Chinese market, it must be registered with the Food and Drug Administration. This requirement is not excessive, and without registration, it is Punishing counterfeit drugs is nothing more than strict enforcement of the drug review system. Therefore, although it is regarded as a life-saving straw by patients, cheap generic drugs from India are not completely innocent when they are deemed to be fake drugs.
In fact, the reason why generic drugs from India are/or even lower than genuine drugs is not due to the monopoly benefit bonus under the drug approval power as some netizens believe, but because Indian generic drugs have higher prices for expensive drugs. The avoidance of drug patents has been questioned internationally. Not only that, the online purchasing of overseas drugs is indeed a mixed bag due to the lack of necessary supervision. Especially driven by profit, it is an indisputable fact that genuine and fake drugs appear in this channel. It can be seen that it is indeed not objective and fair to question the legitimacy of the current drug approval system just because generic drugs from India are cheap and good. However, patients who cannot afford genuine drugs, out of survival demands, buy low-priced drugs. For counterfeit drugs, after testing the drug on one's own to verify its efficacy, he shared the hope of life with other patients, and was charged with selling counterfeit drugs. When life-saving drugs become counterfeit, the instinct to survive actually violates the law and obviously goes against common sense. In any case, life should enjoy the highest right, and protecting people's right to life should be the original intention of any law and system. The drug approval system and drug patent rights are of course no exception.
For example, the compulsory licensing system for pharmaceutical patents is for public health purposes. For drugs that have obtained patent rights, other companies can be licensed to use them without the consent of the patentee. As for India's generic drug industry, although it has patent flaws, the United Nations has promoted the importance of generic drugs at considerable length in its annual report, believing that the development of the generic drug industry is an important step in improving the health level of third world countries. It is an important guarantee to improve the health status of the people, and commends and affirms India's efforts to strengthen the production of low-cost generic drugs.
In this case, under the background that medical insurance cannot provide effective drug supply and life protection to some special patients, generic drugs as the last salvation can obviously not be simply regarded as fake drugs. Patients should work together to help each other, and should be more closely related to the sale of fake drugs. There is a distinction. In any case, whether to break the law to survive or obey the law and wait to die should not be a Hamlet question for patients.